1. Aerie Pharmaceuticals Appoints Peter J. McDonnell, MD, to the Company's Board of Directors

    Aerie Pharmaceuticals Appoints Peter J. McDonnell, MD, to the Company's Board of Directors

    ... Peter J. McDonnell, M.D., has been appointed to the Company's Board of Directors and will also be a member of both the Nominating and Corporate ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content
  2. Quotes

    1. We are very pleased to welcome Peter to the Company's Board. As a highly respected leader in ophthalmology, his clinical experience and broad business perspective will be invaluable as we continue to grow our glaucoma franchise and advance our clinical pipeline.
    2. I am excited to join Aerie's board. As a clinician, I have seen firsthand the positive impact of Rhopressa® and Rocklatan® on glaucoma patients and look forward to working with the Company's Board and management team as Aerie also addresses the unmet needs in dry eye and retinal disease.
  3. Topics Mentioned